Congo approves use of Ebola vaccine to fight outbreak
Congo's health ministry has approved the use of a new Ebola vaccine (Source: CBC | Health)
Source: CBC | Health - May 29, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

Congo approves use of Ebola vaccination to fight outbreak
KINSHASA (Reuters) - Democratic Republic of Congo's health ministry has approved the use of a new Ebola vaccine to counter an outbreak of the hemorrhagic fever in its northeast that has killed four people, a spokesman said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - May 29, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Congo to test experimental Ebola vaccine as disease re-emerges
WHO hopes Merck drug will quell latest outbreak following successful Guinea trial (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 23, 2017 Category: Pharmaceuticals Source Type: news

Suspected Cases of Ebola Rise to 29 in Democratic Republic of Congo
Aid workers are trying to reach a remote part of the country, where there have been three deaths from the virus. (Source: NYT Health)
Source: NYT Health - May 18, 2017 Category: Consumer Health News Authors: DENISE GRADY Tags: Ebola Virus Vaccination and Immunization World Health Organization Rollin, Pierre E Congo, Democratic Republic of (Congo-Kinshasa) Central African Republic Source Type: news

Researchers Discover First Human Antibodies That Work Against All Ebolaviruses
May 18, 2017—(BRONX, NY)—After analyzing the blood of a survivor of the 2013-16 Ebola outbreak, a team of scientists from academia, industry and the government has discovered the first natural human antibodies that can neutralize and protect animals against all three major disease-causing ebolaviruses. The findings, published online today in the journalCell, could lead to the first broadly effective ebolavirus therapies and vaccines. (Source: Einstein News)
Source: Einstein News - May 18, 2017 Category: Universities & Medical Training Source Type: news

Another Step Toward Ebola Protection
Discovery of critical human antibodies may put scientists closer to new vaccines, treatments Source: HealthDay Related MedlinePlus Pages: Ebola (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 18, 2017 Category: Consumer Health News Source Type: news

Suspected Cases of Ebola Rise to 18 in Democratic Republic of Congo
Aid workers are trying to reach a remote part of the country, where there have been three deaths from the virus and about 400 possible contacts. (Source: NYT Health)
Source: NYT Health - May 18, 2017 Category: Consumer Health News Authors: DENISE GRADY Tags: Ebola Virus Vaccination and Immunization World Health Organization Rollin, Pierre E Congo, Democratic Republic of (Congo-Kinshasa) Central African Republic Source Type: news

Health Officials Discuss Sending Experimental Ebola Vaccine To Congo
A World Health Organization spokesman on Sunday confirmed two Ebola cases in the Democratic Republic of Congo on Sunday, bringing the outbreak’s total to 19 suspected and confirmed cases, including three deaths. Health agencies are now in preliminary discussions about sending an experimental vaccine to the outbreak area. The vaccine, developed in the wake of the 2014 West Africa outbreak, was deemed highly effective last year following a large-scale trial of the vaccine in Guinea in 2015. It has not yet been dispatched to the DRC, but health agencies are considering sending the 300,000 available vaccine dos...
Source: Healthy Living - The Huffington Post - May 15, 2017 Category: Consumer Health News Source Type: news

WHO preparing authorization, logistics for Ebola vaccination in Congo if needed
LONDON (Reuters) - The World Health Organization (WHO) said on Monday its experts have not yet decided whether to use newly developed vaccines to try to contain an outbreak of Ebola in Congo, but officials are making preparations just in case. (Source: Reuters: Health)
Source: Reuters: Health - May 15, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Vaccine alliance says 300,000 doses of Merck's Ebola shot available for emergencies
LONDON (Reuters) - The GAVI global vaccine alliance said on Friday some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak,  after the World Health Organization confirmed a fatal case in Congo. (Source: Reuters: Health)
Source: Reuters: Health - May 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

At Least 1 Person Dead From New Ebola Outbreak In Democratic Republic Of Congo
One person has died from a new outbreak of the Ebola virus in the Democratic Republic of Congo, the World Health Organization confirmed Friday. The country has reported nine suspected cases of the virus and three deaths since April 22, according to WHO communications officer Christoper Lindmeier. Out of the three deaths, one tested positive for Ebola. The #Ebola case in the Democratic Republic of Congo was confirmed by a national reference laboratory in Kinshasa #DRC— WHO (@WHO) May 12, 2017 The cases were discovered in Aketi, a remote region without much access to health facilities, WHO communications offi...
Source: Science - The Huffington Post - May 12, 2017 Category: Science Source Type: news

Target Product Profile for Vaccine Platform Technologies
World Health Organization. 04/24/2017 This two-page document provides an overview of characteristics that should be met by vaccine platform technologies aiming to be used reactively in emergency situations. It is provided in the context of the 2014-16 Ebola epidemic, which demonstrated the need for an ability to develop effective interventions in a timely manner for control of severe emerging infectious diseases. It presents four hypothetical scenarios and how these could affect target product profile (TPP) characteristics. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 9, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

WHO chief praises Guineans for help with Ebola vaccine
The head of the World Health Organization praised Guineans on Thursday for their role in helping to develop a vaccine against the deadly Ebola virus. (Source: CBC | Health)
Source: CBC | Health - May 4, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

The World Is Not Ready for the Next Pandemic
Across China, the virus that could spark the next pandemic is already circulating. It’s a bird flu called H7N9, and true to its name, it mostly infects poultry. Lately, however, it’s started jumping from chickens to humans more readily–bad news, because the virus is a killer. During a recent spike, 88% of people infected got pneumonia, three-quarters ended up in intensive care with severe respiratory problems, and 41% died. What H7N9 can’t do–yet–is spread easily from person to person, but experts know that could change. The longer the virus spends in humans, the better the chance that i...
Source: TIME.com: Top Science and Health Stories - May 4, 2017 Category: Consumer Health News Authors: Bryan Walsh Tags: Uncategorized CDC Disease ebola Gates Foundation MERS outbreak pandemic Zika Source Type: news

Foot pain is common and excruciating. Here ’ s how to treat it.
Have you ever felt smug about meeting your daily step target? Imagine if you met your 11,000-step target every day continuously for more than a week — that's what I did. But my feet paid a price for it. There were a lot of illnesses I was afraid of coming down with in my 10-week internship […]Related:What makes someone donate a kidney to a stranger?A mysterious illness kills 11 young people in Liberia, where Ebola ragedU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a plan (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 4, 2017 Category: Consumer Health News Source Type: news

Opening remarks at the Ebola vaccines for Guinea and the world event
4 May 2017 – At an event held in Conakry, Guinea, Dr Margaret Chan thanked the presidents of Guinea, Liberia, and Sierra Leone for supporting the development of a new Ebola vaccine which provides substantial protection against this highly lethal disease. The close collaboration of Guinea’s national authori ties was a catalysing factors in successful implementation of the WHO vaccine trial. Dr Chan also described several spillover initiatives that are leaving the world better prepared for the next inevitable Ebola outbreak. (Source: WHO Director-General speeches)
Source: WHO Director-General speeches - May 4, 2017 Category: Global & Universal Tags: director-general [subject], director-general [subject], director-general [subject], ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, African Region [region], Guinea [country], Speech [doctype] Source Type: news

SAGE (Strategic Advisory Group of Experts on Immunizations) Meeting of April 2017
World Health Organization. 04/2017 This Web page provides presentations from the April 2017 meeting of the Strategic Advisory Group of Experts on Immunizations (SAGE), including reports from other advisory committees. Session topics included the use of oral cholera vaccines, an update with the development of Ebola vaccines and implications to inform future policy recommendations, and a review of recent diphtheria outbreaks. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 3, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

You just learned you have breast cancer. What ’ s next?
Steven Katz, an internist at the University Michigan, researches how medical decisions are made. Over the last dozen years, he has surveyed 10,000 patients and their doctors to better understand how they discuss a diagnosis and decide to proceed. “Women have taught me a lot,” says Katz. Sorting out various options can be “very confusing […]Related:What makes someone donate a kidney to a stranger?A mysterious illness kills 11 young people in Liberia, where Ebola ragedU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a plan (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 29, 2017 Category: Consumer Health News Source Type: news

People who donate a kidney to a stranger have unusual values and beliefs
'They see it as an obvious choice,' one researcher said.Related:A mysterious illness kills 11 young people in Liberia, where Ebola ragedU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a planTrump nominee to head FDA clears key panel, moves to full Senate for vote (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 28, 2017 Category: Consumer Health News Source Type: news

What makes someone donate a kidney to a stranger?
'They see it as an obvious choice,' one researcher said.Related:A mysterious illness kills 11 young people in Liberia, where Ebola ragedU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a planTrump nominee to head FDA clears key panel, moves to full Senate for vote (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 28, 2017 Category: Consumer Health News Source Type: news

A mysterious illness kills 11 young people in Liberia, where Ebola raged
World Health Organization officials said Friday that they are investigating a troubling report out of Liberia of a “cluster of unexplained illnesses and deaths” in an area several hours from Monrovia. Since April 24, at least 17 people have fallen ill with fever, vomiting, headache, diarrhea. Eleven have died and five are still hospitalized at the Francis Grant […]Related:People who donate a kidney to a stranger have unusual values and beliefsU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a planTrump nominee to head FDA clears key panel, moves to full Senate for ...
Source: Washington Post: To Your Health - April 28, 2017 Category: Consumer Health News Source Type: news

U.S. yellow fever vaccine supply will be gone by this summer, but CDC has a plan
U.S. health officials on Friday warned of a new complication in the fight to contain mosquito-borne viruses spreading around the world: The country's supply of yellow fever vaccine is dwindling and will likely be completely gone by this summer — with no way to make more because of a manufacturing problem. The shortage comes at a troubling time. Multiple […]Related:People who donate a kidney to a stranger have unusual values and beliefsA mysterious illness kills 11 young people in Liberia, where Ebola ragedTrump nominee to head FDA clears key panel, moves to full Senate for vote (Source: Was...
Source: Washington Post: To Your Health - April 28, 2017 Category: Consumer Health News Source Type: news

Early blood signatures of vaccine immunogenicity
Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study on systems analysis of immune responses induced by a highly promising vaccine against Ebola. This result can inform and accelerate rational development of other new vaccines based on living viruses. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 26, 2017 Category: Science Source Type: news

Early blood signatures of vaccine immunogenicity
(University of Gothenburg) Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study from a large European research collaboration on systems analysis of immune responses induced by a highly promising vaccine against Ebola in which the University of Gothenburg is participating. This result can inform and accelerate rational development of other new vaccines based on living viruses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2017 Category: Global & Universal Source Type: news

Frog slime could protect us against future flu epidemic
Conclusion This study has identified a substance in the mucus secreted by a south Indian frog which can kill certain types of flu virus. Researchers often turn to natural substances with known health-giving properties to find potential new drugs for humans. For example, aspirin was developed based on a compound found in willow bark – which had been used in traditional medicine for hundreds of years. Some other drugs – such as some chemotherapy and anticlotting drugs – have also been developed from chemicals found in plants. By isolating the substances that have an effect the researchers can make sure...
Source: NHS News Feed - April 19, 2017 Category: Consumer Health News Tags: Heart/lungs Medication Medical practice Source Type: news

The demands of disease drive science
Producers aim much R&D at targets such as Ebola and HIV for which no vaccine exists (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 19, 2017 Category: Pharmaceuticals Source Type: news

Measuring the safety, efficacy of a vaccine against Ebola virus disease
The 2014--2015 Ebola epidemic affected several countries in West Africa, leading to the death of more than 11,000 people. Although this epidemic of Ebolavirus disease is over, there is no knowing if, when or where another may strike. It is therefore more important than ever to find a reliable vaccine against this deadly disease. Research on vaccines, which was ongoing during the epidemic in West Africa, is now yielding promising results. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 18, 2017 Category: Science Source Type: news

UK to double spending on tropical diseases
£360m to be spent on neglected tropical diseases up to 2022 Related items fromOnMedica Malaria treatment used in UK failed for the first time WHO responded 'too slowly' to Ebola warnings Better use of vaccines could help tackle antimicrobial resistance World ‘not prepared’ for Zika and Ebola Climate change poses major threat to health (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 18, 2017 Category: UK Health Source Type: news

[Feature] Epidemic insurance
In the wake of the West Africa Ebola epidemic that ended in 2015, public health officials, pharmaceutical companies, government scientists, and academic researchers have struggled to improve the way the world responds to outbreaks of emerging infections. The most powerful tool, a vaccine, does not exist for dozens of these diseases and a new push is underway to streamline R&D for these commercially unattractive products. A new organization, the Coalition for Epidemic Preparedness Innovations (CEPI), was launched and has raised half a billion dollars to work on three of these vaccines. GlaxoSmithKline, one of only ...
Source: ScienceNOW - April 14, 2017 Category: Science Authors: Jon Cohen Source Type: news

Integrating Clinical Research into Epidemic Response: The Ebola Experience
National Academies Press. 04/12/2017 This 264-page report assesses the value of the clinical trials held during the 2014-2015 Ebola epidemic and makes recommendations about how the conduct of trials could be improved in the context of a future international emerging or re-emerging infectious disease events. Its goal was to explore and analyzes the scientific and ethical issues related to clinical trial design, conduct, and reporting. Particular emphasis was given to clinical trials for vaccine and therapeutic candidates for Ebola conducted by the international community in settings where there is limited health care and re...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 12, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

Tackling Ebola, from supportive care to vaccines in clinical development
(American Association for the Advancement of Science) A new study reports the first detailed description of the day-by-day immune responses observed during the course of a patient's progression through, and recovery from, Ebola virus disease (EVD). During the EVD outbreak that struck West Africa from 2013 to 2015, more than 28,000 infections were reported, with 11,310 confirmed fatalities. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 12, 2017 Category: Infectious Diseases Source Type: news

New Phase II trial begins in West Africa to assess various Ebola vaccine candidates
A new Phase II clinical trial has begun in West Africa to evaluate three vaccination strategies for the prevention of Ebola virus. (Source: Drug Development Technology)
Source: Drug Development Technology - April 10, 2017 Category: Pharmaceuticals Source Type: news

Ebola: New trial launched in west Africa to evaluate three vaccination strategies
(NIH/National Institute of Allergy and Infectious Diseases) The French National Institute of Health and Medical Research (Inserm), the US National Institutes of Health (NIH) and the London School of Hygiene& Tropical Medicine (LSHTM), in collaboration with health authorities in Guinea and Liberia, are launching a large clinical trial of candidate Ebola vaccines under the aegis of the PREVAC international consortium (Partnership for Research on Ebola VACcination). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 6, 2017 Category: Infectious Diseases Source Type: news

Liberia: Prevail Launches Ebola Vaccine Study Expansion
[New Republic] The Partnership for Research on Ebola Virus in Liberia, PREVAIL, Sunday launched the expansion of the Ebola vaccine study at Redemption Hospital. Known as PREVAC under the co-title PREVAIL V, the study will assess three different test vaccine strategies in an effort to find which show the most promise to prevent or quickly control future Ebola outbreaks. It is a continuation of a previous vaccine effort that began in February 2015 in Liberia. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 5, 2017 Category: African Health Source Type: news

Gizmodo wants you to DIE of radiation: Attacks humanitarian scientist who wants to donate anti-radiation patent to the world
(Natural News) The headline of a character assassination attempt article by a writer at Gizmodo reads, “Google Blacklists Natural News, the Web’s Leading Authority on DIY Ebola Vaccines.” Yes, Matt Novak, a journo-whore who is in love with Hillary Clinton and formerly wrote for BuzzFeed (the ultimate “science” crony liberalist-extreme huckster and shill site), is now a... (Source: NaturalNews.com)
Source: NaturalNews.com - April 4, 2017 Category: Consumer Health News Source Type: news

When Bullets Fly, These Medics Grab Their Packs And Treat Patients On The Run
This article is part of HuffPost’s Project Zero campaign, a yearlong series on neglected tropical diseases and efforts to fight them. Everyone takes work home with them sometimes. But in civil war-torn South Sudan, some health workers take theirs on the run. In areas where armed groups have stormed into hospitals and shot people dead in their beds, or gutted and burned clinics, staff for the medical charity Doctors Without Borders (MSF) at times has had to run with patients and hide in the bush to continue treatment. Last year, a group of MSF health workers in the particularly hard-hit town of Leer, in Unity ...
Source: Healthy Living - The Huffington Post - March 30, 2017 Category: Consumer Health News Source Type: news

He Treated The Very First Ebola Cases 40 Years Ago. Then He Watched The World Forget.
This article is part of HuffPost’s Project Zero campaign, a yearlong series on neglected tropical diseases and efforts to fight them. KINSHASA, Congo ― In early 2014, few people worried that the Ebola virus, which is up to 90 percent fatal, would pose a global threat. So the World Health Organization sent shockwaves around the world when it announced that Ebola was spreading out of control in West Africa. Before the epidemic was over two years later, it had killed thousands of people. They died in terrifying and painful ways, often passing the disease on to family members before and even after death....
Source: Healthy Living - The Huffington Post - March 24, 2017 Category: Consumer Health News Source Type: news

He Treated The Very First Ebola Cases 40 Years Ago. Then He Watched The World Forget.
This article is part of HuffPost’s Project Zero campaign, a yearlong series on neglected tropical diseases and efforts to fight them. KINSHASA, Congo ― In early 2014, few people worried that the Ebola virus, which is up to 90 percent fatal, would pose a global threat. So the World Health Organization sent shockwaves around the world when it announced that Ebola was spreading out of control in West Africa. Before the epidemic was over two years later, it had killed thousands of people. They died in terrifying and painful ways, often passing the disease on to family members before and even after death....
Source: Science - The Huffington Post - March 24, 2017 Category: Science Source Type: news

Where is the Greatest Risk of Infectious Disease Transmission While Onboard an Airplane?
Discussion Airplanesare a global transportation mechanism for the world for passengers and cargo. It is an engine which helps to fuel the global economy. In 2014, over 3.3 billion people traveled to more than 41,000 airports and 50,000 routes across the world. It is possible to travel around the world within about 24 hours. This is shorter than most infectious disease incubation periods. Although entry screening into countries is done, exit screening closer to the source is a better model as noted with the recent Ebola outbreak in west Africa in 2014. Individual infectious disease risk includes the generation rate of the ...
Source: PediatricEducation.org - March 20, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

2-part Ebola vaccine found to be effective
The world should be far better prepared for the next Ebola outbreak, with further promising results on Tuesday showing the potential of a long-lasting vaccine against the deadly virus. (Source: CBC | Health)
Source: CBC | Health - March 15, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

Johnson & Johnson reports that investigational Ebola vaccine regimen induced durable immune response 1 year after vaccination in Phase 1 study
Johnson & Johnson announced that final Phase 1 clinical trial data published in JAMA: The Journal of the American Medical Association show that Janssen Pharmaceutical Companies' investigational "prime-boost" Ebola vaccine regimen induced a durable immune response in 100 percent of healthy volunteers one year following vaccination. (Source: World Pharma News)
Source: World Pharma News - March 15, 2017 Category: Pharmaceuticals Tags: Featured Johnson & Business and Industry Source Type: news

Johnson & Johnson Reports that Investigational Ebola Vaccine Regimen Induced Durable Immune Response 1 Year After Vaccination in Phase 1 Study
(Source: Johnson and Johnson)
Source: Johnson and Johnson - March 14, 2017 Category: Pharmaceuticals Source Type: news

Experimental Ebola vaccine regimen induced durable immune response
A two-vaccine regimen to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical tria. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 14, 2017 Category: Science Source Type: news

Natural compound protects against Zika virus infection and microcephaly
FINDINGSNew UCLA research could lead to the development of a drug that combats several mosquito-borne viruses, including Zika virus. The research reveals that an enzyme produced naturally by the immune system protects animals against Zika virus infection and the neurological damage linked to the virus. The enzyme, called 25-hydroxycholestrol or 25HC, can be manufactured to create a compound that works against a broad range of viruses. The research was led by senior author Genhong Cheng, professor of microbiology, immunology and molecular genetics and a member of theEli and Edythe Broad Center of Regenerative Medicine and S...
Source: UCLA Newsroom: Health Sciences - March 14, 2017 Category: Universities & Medical Training Source Type: news

Two-part Ebola vaccine offers long-lasting protection
(Reuters) - The world should be far better prepared for the next Ebola outbreak, with further promising results on Tuesday showing the potential of a long-lasting vaccine against the deadly virus. (Source: Reuters: Health)
Source: Reuters: Health - March 14, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Experimental Ebola vaccine regimen induced durable immune response, study finds
(NIH/National Institute of Allergy and Infectious Diseases) A two-vaccine regimen to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published March 14 in JAMA. The investigational vaccines included Ad26.ZEBOV, developed by Janssen Vaccines& Prevention B.V., of the Janssen Pharmaceutical Companies of Johnson& Johnson, and MVA-BN-Filo, developed by Bavarian Nordic. The NIAID supported the development and testing of the experimental vaccines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2017 Category: Global & Universal Source Type: news

Ebola vaccines provide immune responses after 1 year
(The JAMA Network Journals) Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2017 Category: Global & Universal Source Type: news

Vaccines do work for pandemic flu
Vaccine against swine flu in 2009 prevented infections and hospitalisations Related items fromOnMedica Tamiflu reduced risk of death in H1N1 influenza pandemic Nasal spray flu vaccine for children proving effective Antenatal flu drugs not linked to newborn risks Flu jab linked to fewer hospitalisations World ‘not prepared’ for Zika and Ebola (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 14, 2017 Category: UK Health Source Type: news

How Hepatitis Became A Hidden Epidemic In Africa
This article was originally published on The Conversation. Read the original article. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - March 10, 2017 Category: Consumer Health News Source Type: news